This Study Will Evaluate the Effectiveness of a Simple Intervention Through a Classical Yankauer Oral Suction Tube, in Decreasing the Sedative Medication Doses Needed to Provide Effective Patient Sedation During Bronchoscopy, Along With Its Effect on Both Patient's and Bronchoscopist Satisfaction

Not Applicable

Completed

• Conditions: Bronchoscopy

• Registration Number: NCT06908109
• Lead Sponsor: American University of Beirut Medical Center

Brief Summary

The aim of this study is to evaluate the effectiveness of a simple intervention through a classical Yankauer oral suction tube, a device known to have a proven safety profile in multiple healthcare settings, in decreasing the sedative and opioid medication doses needed to provide effective patient sedation during bronchoscopy, along with its effect on both patient's and bronchscopist's satisfaction throughout the procedure.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-03-04
• Primary Completion: 2022-10-14
• Study Completion: 2022-10-14
• Study First Submitted: 2025-03-21
• Study First Submitted QC: 2025-03-26
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-02
• Study First Posted: 2025-04-03
• Last Update Posted: 2025-04-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• 18 years or above
• inpatients or outpatients
• scheduled to have a flexible bronchoscopy for one of multiple indications based on their physician's assessment, including the presence of a lung mass or collapse, persistent pulmonary infiltrates, pulmonary infection in the setting of immunosuppression, hemoptysis, or other rare causes like chronic cough.
• patients provided a written informed consent.

Exclusion Criteria

• patients with anatomic oro-pharyngeal abnormalities,
• critically ill patients
• uncooperative patients or inability to provide signed consent by the patient or their legal representative
• coagulopathy or bleeding diathesis
• severe obstructive airway disease
• recent myocardial infarction
• uncontrolled or poorly controlled asthma or chronic obstructive pulmonary disease (COPD)
• pregnancy.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Mean doses of Midazolam and Fentanyl	From enrollment (pre-bronchoscopy) to the end of the bronchoscopic procedure (up to 30 minutes)	From the time of enrollment (pre-bronchoscopy) to the end of the bronchoscopic procedure